Elevated energy expenditure in cancer patients with solid tumours

European Journal of Cancer and Clinical Oncology

Volumn 27, Issue 1, 1991, Pages 9-15

  Hyltander, Anders ^a   Drott, Christer ^a   Körner, Ulla ^a   Sandström, Rolf ^a   Lundholm, Kent ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; METABOLISM; PRIORITY JOURNAL; SOLID TUMOR; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; CACHEXIA; ENERGY METABOLISM; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGE; NEOPLASMS; NUTRITIONAL STATUS; SUPPORT, NON-U.S. GOV'T; THYROID HORMONES; WEIGHT LOSS;

EID: 0026019456     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(91)90050-N     Document Type: Article

References (46)

1. Energy balance and body composition in cancer patients
2. Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas
3. Resting energy expenditure in malnourished patients with and without cancer
4. Energy expenditure in malnourished cancer patients
5. Whole body lipid and energy metabolism in the cancer patient
6. Dietary intakes, resting metabolic rates, and body composition in benign and malignant gastrointestinal disease
7. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer
8. Oxidation and metabolic interconversion in malignant cachexia
9. Glucose metabolism in cachectic patients with colorectal cancer
10. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding
11. Whole body tyrosine flux in relation to energy expenditure in weight-losing cancer patients
12. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients
13. Body fuel oxidation in cancer patients and controls
14. Metabolic balance across the leg in weight losing cancer patients compared to depleted patients without cancer
15. Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross sectional muscle and fat areas
16. Nya längd-vikttabeller för medalålders och äldre män och kvinnor
17. Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight
18. New methods for calculating metabolic rate with special reference to protein metabolism
19. A biometric study of basal metabolism in man
20. Nutritional and metabolic assessment of the hospitalized patient
21. Thyroid hormones in conditions of chronic malnutrition
22. Perspectives in Inflammation, neoplasia, and vascular cell biology
23. Cardiac sensitivity and responsiveness to beta-adrenergic stimulation in experimental cancer and undernutrition
24. Effects of total parenteral nutrition and chemotherapy on the metabolic derangments in small cell lung cancer
25. Increased urinary excretion of cortisol and catecholamines in malnourished cancer patients
26. Cardiovascular and metabolic response to adrenaline infusion in undernourished patients with and without cancer
27. Cardiovascular β-adrenoceptor sensitivity of undernourished subjects
28. Effect of caloric restriction on cardiac reactivity and beta-adrenoceptor concentration
29. The role of catecholamines and thyroid hormones in the metabolic response to semistarvation
30. Effects of malnutrition on rat myocardial B-adrenergic and muscarinic receptors
31. Cachectin and tumour necrosis factor as two sides of the same biological coin
32. Interleukin 1 and the pathogenesis of the acute phase response
33. Cytokines regulating acute inflammation and synthesis of acute phase proteins
34. Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia
35. Cachectin-tumor necrosis factor induces cachexia, anemia, and inflammation
36. Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines
37. Shock and tissue injury induced by recombinant human cachectin
38. Metabolic response to infection
39. Modulation of endogenous hormone action by recombinant human tumor necrosis factor
40. Tumors secreting human TNF-cachectin induce cachexia in mice
41. Anticacechtin-tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models
42. Monocytic production and plasma bioactivitie of interleukin-1 and tumour necrosis factor in human cancer
43. Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat